CliffBio
small molecule

MYCOPHENOLATE MOFETIL

MYCOPHENOLATE MOFETIL

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameMYCOPHENOLATE MOFETIL
Active ingredientMYCOPHENOLATE MOFETIL
Strength500MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 2009
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.